文献速递眼整形与眼眶神经眼科

鼻眶脑型毛霉病患者的生存结局及其影响因素

Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis.
PubMed 文献 · Br J Ophthalmol · 2018-12-04

该回顾性研究纳入2008-2016年一家大学医院的63例活检证实鼻眶脑型毛霉病患者(79眼),分析患者、眼球和视力生存率及其影响因素。结果显示患者生存率为57.1%,眼球生存率为43%,视力生存率为25.3%;冰冻眼、鼻黏膜受累和抗真菌治疗时间较短与患者生存率降低显著相关,眼球摘除未显著改变生存率。

要点

  • 鼻眶脑型毛霉病患者生存率57.1%,眼球生存率43%,视力生存率25.3%。
  • 冰冻眼、鼻黏膜受累和抗真菌治疗时间较短与患者生存率降低显著相关。
  • 较高白细胞计数与较低眼球生存率相关,眼球摘除未显著改变患者生存率。

核心结论

  • 患者、眼球和视力生存率分别为57%、43%和25%。
  • 眼球摘除未影响患者生存率。
  • 冰冻眼和鼻黏膜受累与较低生存率显著相关,较高白细胞计数显著增加眼球摘除风险。

研究设计与样本

  • 回顾性研究,纳入2008-2016年一家大学医院的63例活检证实鼻眶脑型毛霉病患者(79眼)。

主要发现

  • 平均年龄55.5岁(SD 12.9),无性别偏好。
  • 糖尿病是最常见的基础疾病(68.3%)。
  • 患者生存率为57.1%(36/63)。
  • 眼球生存率为43%(34/79),视力生存率为25.3%(20/79)。
  • 冰冻眼(OR 4.6)、鼻黏膜受累(OR 7.3)和抗真菌治疗时间较短(OR 1.03)与较低患者生存率显著相关。

临床怎么用

  • 应关注冰冻眼、鼻黏膜受累及抗真菌治疗时长对患者生存的影响。
  • 眼球摘除决策需综合评估,其未显著改变患者生存率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To report the frequency and factors affecting patients', globe and vision survivals in rhino-orbito-cerebral mucormycosis (ROCM). METHODS: This is a retrospective study of 63 patients (79 eyes) with biopsy-proven ROCM at a university hospital 2008-2016. Systemic and ophthalmic manifestations, imaging, management and final outcomes were recorded. Globe survival was defined as no exenteration and vision survival as final visual acuity of light perception and more. RESULTS: Mean age was 55.5 (SD 12.9) years with no gender preference. Diabetes was the most common underlying disease (68.3%). Patient survival was observed in 57.1 % (36/63). Presence of frozen eye (OR 4.6), nasal mucosal involvement (OR 7.3) and shorter duration of antifungal therapy (OR 1.03) were significantly associated with lower patient survival. Exenteration did not significantly change the survival. Globe survival was detected in 43% (34/79). Higher white blood cell (WBC) count was associated with a lower globe survival (p=0.02). Vision survival was observed in 25.3% (20/79) in whom younger age was significantly associated with a worse vision survival. CONCLUSION: Patient, globe and vision survivals were 57%, 43% and 25%, respectively. Exenteration did not affect the patients' survival. While frozen eye and nasal mucosal involvement were significantly associated with a lower survival, higher WBC count significantly increased the risk of exenteration.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Kashkouli MB, Abdolalizadeh P, Oghazian M, et al. Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis. Br J Ophthalmol. 2018. PMID: 30514712. doi:10.1136/bjophthalmol-2018-312688

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。